DK137083D0 - Fremgangsmade til fremstilling af 26,26,26,27,27,27-hexafluorlalfa,25-dihydroxycholecalciferol og mellemprodukter til brug herved - Google Patents

Fremgangsmade til fremstilling af 26,26,26,27,27,27-hexafluorlalfa,25-dihydroxycholecalciferol og mellemprodukter til brug herved

Info

Publication number
DK137083D0
DK137083D0 DK1370/83A DK137083A DK137083D0 DK 137083 D0 DK137083 D0 DK 137083D0 DK 1370/83 A DK1370/83 A DK 1370/83A DK 137083 A DK137083 A DK 137083A DK 137083 D0 DK137083 D0 DK 137083D0
Authority
DK
Denmark
Prior art keywords
hexafluorlalfa
dihydroxycholecalciferol
intermediates
preparing
Prior art date
Application number
DK1370/83A
Other languages
English (en)
Other versions
DK162282C (da
DK137083A (da
DK162282B (da
Inventor
Hector F Deluca
Yoko Tanaka
Nobuo Ikekawa
Yoshiro Kobayashi
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of DK137083A publication Critical patent/DK137083A/da
Publication of DK137083D0 publication Critical patent/DK137083D0/da
Priority to DK554084A priority Critical patent/DK165695C/da
Publication of DK162282B publication Critical patent/DK162282B/da
Application granted granted Critical
Publication of DK162282C publication Critical patent/DK162282C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK137083A 1981-07-27 1983-03-25 Analogifremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholecalciferoler samt 26,26,26-27,27,27-hexafluor-1alfa,3beta,25-trihydroxycholest-5,7-dien til anvendelse som udgangsmateriale ved fremgangsmaaden DK162282C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK554084A DK165695C (da) 1981-07-27 1984-11-22 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28679081 1981-07-27
US06/286,790 US4358406A (en) 1981-07-27 1981-07-27 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same
US8200909 1982-07-06
PCT/US1982/000909 WO1983000335A1 (en) 1981-07-27 1982-07-06 26,26,26,27,27,27-HEXAFLUORO-1'alpha',25-DIHYDROXYCHOLECALCIFEROL AND PROCESS FOR PREPARING SAME

Publications (4)

Publication Number Publication Date
DK137083A DK137083A (da) 1983-03-25
DK137083D0 true DK137083D0 (da) 1983-03-25
DK162282B DK162282B (da) 1991-10-07
DK162282C DK162282C (da) 1992-03-16

Family

ID=23100174

Family Applications (2)

Application Number Title Priority Date Filing Date
DK137083A DK162282C (da) 1981-07-27 1983-03-25 Analogifremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholecalciferoler samt 26,26,26-27,27,27-hexafluor-1alfa,3beta,25-trihydroxycholest-5,7-dien til anvendelse som udgangsmateriale ved fremgangsmaaden
DK554084A DK165695C (da) 1981-07-27 1984-11-22 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK554084A DK165695C (da) 1981-07-27 1984-11-22 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol

Country Status (14)

Country Link
US (1) US4358406A (da)
JP (1) JPS58501176A (da)
AU (2) AU552210B2 (da)
BE (1) BE893943A (da)
CH (2) CH656134A5 (da)
DE (2) DE3250034C2 (da)
DK (2) DK162282C (da)
FR (1) FR2510566B1 (da)
GB (2) GB2102806B (da)
IE (2) IE54369B1 (da)
IL (5) IL76090A (da)
IT (1) IT1157309B (da)
NL (1) NL8220265A (da)
WO (1) WO1983000335A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634692A (en) * 1981-08-28 1987-01-06 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxy-24R-fluorocholecalciferol and 1α,25-dihydroxy-24S-fluorocholecalciferol
US4411833A (en) * 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
US4448726A (en) * 1983-05-11 1984-05-15 Wisconsin Alumni Research Foundation Ring A- and triene-modified vitamin D compounds
US4613594A (en) * 1984-11-16 1986-09-23 Hoffmann-La Roche Inc. Fluorinated vitamin D3 compounds
ZA859138B (en) * 1984-12-19 1986-08-27 Hoffmann La Roche Cholecalciferol derivatives
EP0205025A1 (en) * 1985-05-27 1986-12-17 Sumitomo Pharmaceuticals Company, Limited Fluorine derivatives of vitamin D3 and cell differentiation-inducing agents containing the same as an active ingredient
US4619920A (en) * 1985-09-16 1986-10-28 Wisconsin Alumni Research Foundation 26,26,26,27,27-pentafluoro-1α-hydroxy-27-methoxyvitamin D3
JPH0764804B2 (ja) * 1986-04-25 1995-07-12 住友製薬株式会社 活性型ビタミンｄ３のフッ素誘導体
CA1314872C (en) 1986-04-25 1993-03-23 Toshio Nishizawa Fluorine derivatives of vitamin d _and process for producing the same
US4853378A (en) * 1986-10-20 1989-08-01 Sumitomo Chemical Company, Limited Fluorine derivatives of vitamin D3 and process for producing the same
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
WO1990009179A1 (en) * 1989-02-16 1990-08-23 University Of Georgia Research Foundation, Inc. Treatment of tibial dyschondroplasia
JP3708115B2 (ja) * 1991-05-06 2005-10-19 ザ プロクター アンド ギャンブル カンパニー 混合カルシウム及びビタミンｄ補給品
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5753638A (en) * 1992-10-07 1998-05-19 Hoffmann-La Roche Inc. Method of treating hyperproliferative skin disease with Vitamin D3 fluorinated analogs
DE69327906T2 (de) * 1992-10-16 2000-10-05 Chugai Pharmaceutical Co Ltd Vitamin-d-derivat und verfahren zu seiner herstellung
WO1994018985A1 (en) * 1993-02-19 1994-09-01 Wisconsin Alumni Research Foundation USE OF 26,26,26,27,27,27-HEXAFLUORO-1α,25-DIHYDROXYCHOLECALCIFEROL FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS
US5547947A (en) * 1993-03-11 1996-08-20 Hoffmann-La Roche Inc. Methods of treatment
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
US6080879A (en) * 1998-05-19 2000-06-27 Tetrionics, Inc. Hexafluoro-vitamin synthesis and crystallization method, solvent and product
MX2010007266A (es) * 2007-12-28 2010-11-30 Wisconsin Alumni Res Found Análogos de vitamina d, (20s)-23, 23-difluoro-2-metilen-19-nor-bis homopregnacalciferol.
KR101991692B1 (ko) 2009-01-27 2019-06-21 베르그 엘엘씨 화학요법과 연관된 부작용을 경감시키기 위한 비타민 ｄ３ 및 이의 유사물
EA201270226A1 (ru) 2009-08-14 2012-09-28 БЕРГ БАЙОСИСТЕМЗ, ЭлЭлСи Витамин d3 и его аналогии для лечения алопеции
EP3003497B1 (en) 2013-05-29 2024-02-14 BPGbio, Inc. Preventing or mitigating chemotherapy induced alopecia using vitamin d
ES2536256B2 (es) 2013-11-20 2016-02-01 Universidade De Santiago De Compostela Análogos de vitamina d con interés farmacéutico
CN111960938B (zh) * 2020-08-20 2022-06-17 甘肃皓天医药科技有限责任公司 用于制备氟骨化醇的中间体的制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL45897A (en) * 1974-10-22 1978-12-17 Yeda Res & Dev Process for the preparation of 1 hydroxy-provitamin d3
US4199518A (en) * 1978-03-30 1980-04-22 Diamond Shamrock Corporation 1α,3β-Dihydroxy-steroid-5-enes from 1α,2α-epoxy-steroid-4,6-dien-3-ones
PH16989A (en) * 1978-11-07 1984-05-04 Res Inst Medicine Chem Process for the preparation of 1-hydroxylated vitamin d compounds
US4226788A (en) * 1979-03-28 1980-10-07 Wisconsin Alumni Research Foundation 24,24-Difluoro-1α,25-dihydroxycholecalciferol
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol

Also Published As

Publication number Publication date
US4358406A (en) 1982-11-09
GB2118556A (en) 1983-11-02
GB2118556B (en) 1985-02-27
IE891226L (en) 1983-01-27
IT8222574A0 (it) 1982-07-26
DK165695B (da) 1993-01-04
IE54369B1 (en) 1989-09-13
BE893943A (fr) 1982-11-16
CH656134A5 (de) 1986-06-13
DE3248900T1 (de) 1983-07-07
CH655307A5 (de) 1986-04-15
AU586267B2 (en) 1989-07-06
IL76090A (en) 1987-12-31
WO1983000335A1 (en) 1983-02-03
AU8760582A (en) 1983-03-17
GB8311517D0 (en) 1983-06-02
DK162282C (da) 1992-03-16
IL76090A0 (en) 1985-12-31
AU6056086A (en) 1986-12-18
DK137083A (da) 1983-03-25
GB2102806A (en) 1983-02-09
JPH0348903B2 (da) 1991-07-25
DE3250034C2 (da) 1991-02-28
IE821797L (en) 1983-01-27
JPS58501176A (ja) 1983-07-21
AU552210B2 (en) 1986-05-22
IL76091A (en) 1987-12-31
DK165695C (da) 1993-06-07
DK554084D0 (da) 1984-11-22
DE3248900C2 (da) 1990-12-13
IT1157309B (it) 1987-02-11
FR2510566A1 (fr) 1983-02-04
NL8220265A (nl) 1983-06-01
IE54370B1 (en) 1989-09-13
IL66351A (en) 1987-12-31
IL66351A0 (en) 1982-11-30
IL76091A0 (en) 1985-12-31
FR2510566B1 (fr) 1985-06-28
GB2102806B (en) 1985-02-27
DK162282B (da) 1991-10-07
DK554084A (da) 1984-11-22

Similar Documents

Publication Publication Date Title
DK137083D0 (da) Fremgangsmade til fremstilling af 26,26,26,27,27,27-hexafluorlalfa,25-dihydroxycholecalciferol og mellemprodukter til brug herved
DK164684D0 (da) 4-substituerede-2-azetidinon-forbindelser,fremgangsmaade til fremstilling heraf og mellemprodukter til brug herved
DK516182A (da) Fremgangsmaade til fremstilling af 3-hydroxy-ml-236b derivater, betegnet m-4 og m-4'
DK304781A (da) Formdel og fremgansmaade til fremstolling heraf
DK172485D0 (da) 23,23-difluor-1,25-dihydroxycholecalciferol og derivater deraf, fremgangsmaade til fremstilling af disse og mellemprodukter til brug herved
NO164506C (no) Strippemiddel og anvendelse derav.
DK56782A (da) Fremgangsmaade og middel til boelgning eller udretning af haar
DK261782A (da) Overfladebehandlingsmetode og praeparat til cement
DK32684D0 (da) Fremgangsmade til fremstilling af 26,26,26,27,27,27-hexafluorlalfa,25-dihydroxycholesterol og mellemprodukter til brug herfor
DK116282A (da) Kosmetisk praeparat og fremgangsmaade til dets fremstilling
DK436981A (da) Fremgangsmaade til fremstilling af 25-hydroxy26,26,26,27,27,27,-hexafluor-cholecalciferol og mellemprodukter herved
DK149842C (da) Fremgangsmaade til fremstilling af d-camphorat af l-carnitinamid og d-camphorat af d-carnitinamid
DK145983D0 (da) Fremgangsmade til fremstilling af quinolonforbindelser og mellemprodukter til brug herved
DK215490A (da) Fremgangsmaade til fremstilling af 10-substituerede 1,8-dihydroxy-9-anthroner
DK505080A (da) Fremgangsmaade til fremstilling af 24,24-difluor1alfa,25-dihydroxycholecalciferol og mellemprodukter til brug ved fremgangsmaaden
DK145885A (da) Stroemningsreaktor og fremgangsmaade til fremstilling deraf
DK127182A (da) Fremgangsmaade til fremstilling af 1,1-dioxopenicillanoyloxymethyl-6-(2-phenylacetamido)penicillanater og mellemprodukter herved
PL238064A1 (en) Herbicide and method of manufacture of fluorine containing 4,6-diamino-s-triazines and their intermediates
DK565482A (da) Fremgangsmaade til fremstilling af 1,1-alkandiol-dicarboxylsyreestere, og mellemprodukter for disse estere
DK501582A (da) Fremgangsmaade til fremstilling af acylcyanider
DK274882A (da) Fremgangsmaade til fremstilling af 4alfa,5alfa-epoxy-3,20-dioxopregnen-2alfa,16alfa-dicarbonitril og mellemprodukt herved
IT8212605A0 (it) Metodo ed apparecchio per la deodo rizzazione di ambienti
DK232184D0 (da) Fremgangsmaade til fremstilling af 4-halogenmethylthiazoler og mellemprodukt til brug ved fremgangsmaaden
DK76482A (da) Fremgangsmaade til fremstilling af antibiotikaene ll-b01208alfa og ll-b01208beta
DK326082A (da) Heptadecapeptid og fremgangsmaade til fremstilling heraf

Legal Events

Date Code Title Description
PBP Patent lapsed